CC BY-NC-ND 4.0 · Eur J Dent 2020; 14(03): 483-495
DOI: 10.1055/s-0040-1712718
Review Article

Cytokines and Chemokines in Periodontitis

Doaa Elsayed Ramadan
1   Dental Health Science Postgraduate Program, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
,
Ninuk Hariyani
1   Dental Health Science Postgraduate Program, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
2   Department of Dental Public Health, Faculty of Dental Medicine, Universitas Airlangga, Indonesia
,
Retno Indrawati
1   Dental Health Science Postgraduate Program, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
,
Rini Devijanti Ridwan
1   Dental Health Science Postgraduate Program, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
,
Indeswati Diyatri
1   Dental Health Science Postgraduate Program, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
› Author Affiliations

Abstract

Periodontitis is a common inflammatory periodontal disease affecting a wide range of population all over the world. The causing bacteria releases chemicals which activate the innate immune system to release proinflammatory cytokines contributing to more progression. This activates the acquired immune system leading to more progression of periodontitis. As the immune response goes on, released cytokines and chemokines can damage the periodontal ligaments, gingiva, and alveolar bone. There are many types of cytokines and chemokines in periodontitis. Cytokines are peptide mediators who are responsible for cell signaling and communication. Chemokines are a large subfamily of cytokines having the ability to coordinate leukocyte recruitment and activation. This paper is a narrative review of the literature.This review ensures that inflammatory mediators in the case of periodontitis can cause a noticeable damage in the whole apparatus of the periodontium. It causes soft tissue inflammation and bone damage affected by the mediators of both innate and acquired immune system.The inflammatory process is accompanied by large network of cytokines and chemokines. There is high expression of proinflammatory cytokines such as interleukin (IL)-1α, IL-1β, IL-6, IL-12, tumor necrosis factor (TNF)-α, and regulatory cytokines such as IL-4, IL-1(RA) receptor antagonist, IL-10, and induced protein (IP)-10. There is also increased production of cytokines IL-10, IL-12, interferon-γ, IP-10, IL-1RA, and IL-4. Cytokines IL-17, IL-6, IL-1β, TNF-α, macrophage colony-stimulating factor, and prostaglandin E2 trigger the osteoclast activity causing bone resorption.



Publication History

Article published online:
23 June 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Newman MG. et al. Carranza’s Clinical Periodontology. Elsevier Health Sciences; 2011: 1305-7456
  • 2 Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366 (9499) 1809-1820
  • 3 Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008; 79 (8, Suppl) 1585-1591
  • 4 Heidari Z, Moudi B, Mahmoudzadeh-Sagheb H. Immunomodulatory factors gene polymorphisms in chronic periodontitis: an overview. BMC Oral Health 2019; 19 (01) 29
  • 5 Buduneli N, Kinane DF. Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol 2011; 38 (Suppl 11) 85-105
  • 6 Hasan A, Palmer RM. A clinical guide to periodontology: pathology of periodontal disease. Br Dent J 2014; 216 (08) 457-461
  • 7 Andrukhov O, Ulm C, Reischl H, Nguyen PQ, Matejka M, Rausch-Fan X. Serum cytokine levels in periodontitis patients in relation to the bacterial load. J Periodontol 2011; 82 (06) 885-892
  • 8 Gemmell E, Marshall RI, Seymour GJ. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 1997; 14 (01) 112-143
  • 9 Di Benedetto A, Gigante I, Colucci S, Grano M. Periodontal disease: linking the primary inflammation to bone loss. Clin Dev Immunol 2013; 2013: 503754
  • 10 Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev 2012; 76 (01) 16-32
  • 11 Kleiner G, Marcuzzi A, Zanin V, Monasta L, Zauli G. Cytokine levels in the serum of healthy subjects. Mediators Inflamm 2013; 2013: 434010
  • 12 Bonecchi R, Galliera E, Borroni EM, Corsi MM, Locati M, Mantovani A. Chemokines and chemokine receptors: an overview. Front Biosci 2009; 14 (01) 540-551
  • 13 Armitage GC, Cullinan MP. Comparison of the clinical features of chronic and aggressive periodontitis. Periodontol 2000 2010; 53 (01) 12-27
  • 14 Socransky SS, Haffajee AD, Cugini MA. Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998; 25 (02) 134-144
  • 15 Balashova N, Dhingra A, Boesze-Battaglia K, Lally ET. Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells. Mol Oral Microbiol 2016; 31 (01) 106-114
  • 16 Gölz L, Memmert S, Rath-Deschner B. et al. LPS from P. gingivalis and hypoxia increases oxidative stress in periodontal ligament fibroblasts and contributes to periodontitis. Mediators Inflamm 2014; 2014: 986264
  • 17 Sorsa T, Mäntylä P, Tervahartiala T, Pussinen PJ, Gamonal J, Hernandez M. P activation in diagnostics of periodontitis and systemic inflammation. J Clin Periodontol 2011; 38 (09) 817-819
  • 18 Kachlany SC. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy. J Dent Res 2010; 89 (06) 561-570
  • 19 Kapoor U, Sharma G, Juneja M, Nagpal A. Halitosis: current concepts on etiology, diagnosis and management. Eur J Dent 2016; 10 (02) 292-300
  • 20 Song B, Zhang YL, Chen LJ. et al. The role of toll-like receptors in periodontitis. Oral Dis 2017; 23 (02) 168-180
  • 21 Zhang Y, Li X. Lipopolysaccharide-regulated production of bone sialoprotein and interleukin-8 in human periodontal ligament fibroblasts: the role of toll-like receptors 2 and 4 and the MAPK pathway. J Periodontal Res 2015; 50 (02) 141-151
  • 22 Wara-aswapati N, Chayasadom A, Surarit R. et al. Induction of toll-like receptor expression by porphyromonas gingivalis. J Periodontol 2013; 84 (07) 1010-1018
  • 23 Kawai T, Akira S. Differentiation, TLR signaling. Cell Death 2006; 13 (05) 816
  • 24 Schuch HS, Peres KG, Demarco FF. et al. Effect of life-course family income trajectories on periodontitis: birth cohort study. J Clin Periodontol 2018; 45 (04) 394-403
  • 25 Lertpimonchai A, Rattanasiri S, Arj-Ong S Vallibhakara, Attia J, Thakkinstian A. The association between oral hygiene and periodontitis: a systematic review and meta-analysis. Int Dent J 2017; 67 (06) 332-343
  • 26 Ashraf M Nazir, Almas K. Awareness about the effects of tobacco consumption on oral health and the possibility of smoking behavior among male Saudi schoolchildren. Eur J Dent 2017; 11 (01) 29-35
  • 27 Sakki TK, Knuuttila ML, Vimpari SS, Hartikainen MS. Association of lifestyle with periodontal health. Community Dent Oral Epidemiol 1995; 23 (03) 155-158
  • 28 Castro MM, Ferreira RO, Fagundes NCF, Almeida APCPSC, Maia LC, Lima RR. Association between psychological stress and periodontitis: a systematic review. Eur J Dent 2020; 14 (01) 171-179
  • 29 Kim J, Amar S. Periodontal disease and systemic conditions: a bidirectional relationship. Odontology 2006; 94 (01) 10-21
  • 30 Meyle J, Dommisch H, Groeger S, Giacaman RA, Costalonga M, Herzberg M. The innate host response in caries and periodontitis. J Clin Periodontol 2017; 44 (12) 1215-1225
  • 31 Kumaresan D, Balasundaram A, Naik VK, Appukuttan DP. Gingival crevicular fluid periostin levels in chronic periodontitis patients following nonsurgical periodontal treatment with low-level laser therapy. Eur J Dent 2016; 10 (04) 546-550
  • 32 Lindhe J, Lang NP, Karring T. Text Book of Clinical Periodontology and Implant Dentistry. Copenhagen: Munksgaard; 2003
  • 33 Cairo F, Nieri M, Gori AM. et al. Markers of systemic inflammation in periodontal patients: chronic versus aggressive periodontitis. An explorative cross-sectional study. Eur J Oral Implantology 2010; 3 (02) 147-153
  • 34 Giacaman RA, Asrani AC, Ross KF, Herzberg MC. Cleavage of protease-activated receptors on an immortalized oral epithelial cell line by Porphyromonas gingivalis gingipains. Microbiology 2009; 155 (Pt 10) 3238-3246
  • 35 Beklen A, Hukkanen M, Richardson R, Konttinen YT. Immunohistochemical localization of toll-like receptors 1-10 in periodontitis. Oral Microbiol Immunol 2008; 23 (05) 425-431
  • 36 Dommisch H, Reinartz M, Backhaus T, Deschner J, Chung W, Jepsen S. Antimicrobial responses of primary gingival cells to Porphyromonas gingivalis. J Clin Periodontol 2012; 39 (10) 913-922
  • 37 Hosokawa I, Hosokawa Y, Ozaki K, Yumoto H, Nakae H, Matsuo T. Proinflammatory effects of muramyldipeptide on human gingival fibroblasts. J Periodontal Res 2010; 45 (02) 193-199
  • 38 Baek KJ, Choi Y, Ji S. Gingival fibroblasts from periodontitis patients exhibit inflammatory characteristics in vitro. Arch Oral Biol 2013; 58 (10) 1282-1292
  • 39 Jung YJ, Choi YJ, An SJ, Lee HR, Jun HK, Choi BK. Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. Mol Oral Microbiol 2017; 32 (04) 301-313
  • 40 Marki A, Esko JD, Pries AR, Ley K. Role of the endothelial surface layer in neutrophil recruitment. J Leukoc Biol 2015; 98 (04) 503-515
  • 41 White P, Cooper P, Milward M, Chapple I. Differential activation of neutrophil extracellular traps by specific periodontal bacteria. Free Radic Biol Med 2014; 75 (Suppl 1) S53
  • 42 White PC, Chicca IJ, Cooper PR, Milward MR, Chapple IL. Neutrophil extracellular traps in periodontitis: a web of intrigue. J Dent Res 2016; 95 (01) 26-34
  • 43 Alfakry H, Malle E, Koyani CN, Pussinen PJ, Sorsa T. Neutrophil proteolytic activation cascades: a possible mechanistic link between chronic periodontitis and coronary heart disease. Innate Immun 2016; 22 (01) 85-99
  • 44 Hajishengallis G, Chavakis T, Hajishengallis E, Lambris JD. Neutrophil homeostasis and inflammation: novel paradigms from studying periodontitis. J Leukoc Biol 2015; 98 (04) 539-548
  • 45 Hasturk H, Kantarci A. Activation and resolution of periodontal inflammation and its systemic impact. Periodontol 2000 2015; 69 (01) 255-273
  • 46 Stadler AF, Angst PD, Arce RM, Gomes SC, Oppermann RV, Susin C. Gingival crevicular fluid levels of cytokines/chemokines in chronic periodontitis: a meta-analysis. J Clin Periodontol 2016; 43 (09) 727-745
  • 47 Ford PJ, Gamonal J, Seymour GJ. Immunological differences and similarities between chronic periodontitis and aggressive periodontitis. Periodontol 2000 2010; 53 (01) 111-123
  • 48 Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta 2014; 1843 (11) 2563-2582
  • 49 Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17 (03) 138-146
  • 50 Harrington LE, Hatton RD, Mangan PR. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6 (11) 1123-1132
  • 51 Araujo-Pires AC, Francisconi CF, Biguetti CC. et al. Simultaneous analysis of T helper subsets (Th1, Th2, Th9, Th17, Th22, Tfh, Tr1 and Tregs) markers expression in periapical lesions reveals multiple cytokine clusters accountable for lesions activity and inactivity status. J Appl Oral Sci 2014; 22 (04) 336-346
  • 52 Feghali CA, Wright TM. Cytokines in acute and chronic inflammation. Front Biosci 1997; 2 (01) d12-d26
  • 53 Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis. ? J Clin Periodontol 2011; 38 (Suppl. 11) 60-84
  • 54 Goldbach-Mansky R. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immunol 2012; 167 (03) 391-404
  • 55 Comerford I, McColl SR. Mini-review series: focus on chemokines. Immunol Cell Biol 2011; 89 (02) 183-184
  • 56 Braz-Silva PH, Bergamini ML, Mardegan AP. De Rosa CS, Hasseus B, Jonasson P. Inflammatory profile of chronic apical periodontitis: a literature review. Acta Odontol Scand 2019; 77 (03) 173-180
  • 57 Silva TA, Garlet GP, Lara VS. Martins W Jr, Silva JS, Cunha FQ. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases. Oral Microbiol Immunol 2005; 20 (05) 310-316
  • 58 Azuma MM, Samuel RO, Gomes-Filho JE, Dezan-Junior E, Cintra LT. The role of IL-6 on apical periodontitis: a systematic review. Int Endod J 2014; 47 (07) 615-621
  • 59 Wells TN, Power CA, Proudfoot AE. Definition, function and pathophysiological significance of chemokine receptors. Trends Pharmacol Sci 1998; 19 (09) 376-380
  • 60 de Carvalho Fraga CA, Alves LR, de Sousa AA. et al. Th1 and Th2-like protein balance in human inflammatory radicular cysts and periapical granulomas. J Endod 2013; 39 (04) 453-455
  • 61 Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003; 74 (03) 391-401
  • 62 Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol 2008; 79 (08) (Suppl) 1569-1576
  • 63 Lerner UH. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res 2006; 85 (07) 596-607
  • 64 Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003; 423 (6937) 337-342
  • 65 Bascones A, Noronha S, Gómez M, Mota P, Gónzalez Moles MA, Villarroel Dorrego M. Tissue destruction in periodontitis: bacteria or cytokines fault?. Quintessence Int 2005; 36 (04) 299-306
  • 66 Nakashima T, Kobayashi Y, Yamasaki S. et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 2000; 275 (03) 768-775
  • 67 Yucel-Lindberg T, Båge T. Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med 2013; 15: e7
  • 68 Chatterjee D, Kapoor A, Vijay S, Sobti G, Kara D, Thanvi J. Efficacy of locally administered 1.2% rosuvastatin gel in patients with periodontitis: a randomized placebo controlled clinical trial. Eur J Dent 2019; 13 (01) 29-35